General Announcement::40th Annual General Meeting - September 28, 2018

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
21-Aug-2018 21:07:16
Status
New
Announcement Sub Title
40th Annual General Meeting - September 28, 2018
Announcement Reference
SG180821OTHRFQEL
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
21/08/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
We have to inform you that the 40th Annual General Meeting (AGM) of Members of the Company is scheduled to be held on Friday, September 28, 2018 at 11.00 a.m. at Sunville Banquets & Conference Hall, 3rd floor, Dr. Annie Besant Road, Worli, Mumbai - 400 018. The copy of the notice will be sent to you in due course.

Pursuant to the Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that the Register of Members and the Share Transfer Books of the Company will remain closed from Saturday, September 22, 2018 to Friday, September 28, 2018 (both days inclusive) for the purpose of the AGM and determining the names of the eligible Members for equity dividend.

The dividend, if approved by the Members at the ensuing AGM, will be paid on or after October 3, 2018.

Attachments

BSE_NSE_Intimation.pdf
Total size =323K